Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells

Expanded access is currently available for this treatment.
Verified August 2012 by Meir Medical Center
Sponsor:
Collaborator:
Tel Aviv University
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01267461
First received: December 27, 2010
Last updated: August 9, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given